The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count

Programmed cell death ligand‐1 (PD‐L1) is a ligand for programmed cell death‐1 (PD‐1) that negatively regulates T‐cell activation and plays a crucial role in suppressing anti‐tumor host immunity. Although PD‐L1 is a promising immunotherapy target in various cancers, including urothelial carcinoma (U...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyama, Yu, Morikawa, Teppei, Miyakawa, Jimpei, Koyama, Yuichi, Kawai, Taketo, Kume, Haruki, Fukayama, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143937/
https://www.ncbi.nlm.nih.gov/pubmed/30062756
http://dx.doi.org/10.1002/cam4.1686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143937/
https://www.ncbi.nlm.nih.gov/pubmed/30062756
http://dx.doi.org/10.1002/cam4.1686

Ejemplares similares